Logotype for Telesis Bio Inc

Telesis Bio (DNAY) investor relations material

Telesis Bio Q3 2024 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Telesis Bio Inc
Q3 2024 earnings summary7 Nov, 2024

Executive summary

  • Revenue for the nine months ended September 30, 2024 was $5.3 million, down from $15.8 million year-over-year, with a net loss of $27.9 million compared to $30.0 million in 2023.

  • The company completed the sale of its EtonBio subsidiary in August 2024, which is now reflected as a discontinued operation.

  • Telesis Bio's common stock was delisted from Nasdaq in September 2024 and now trades on the OTC Pink market.

  • As of September 30, 2024, cash, cash equivalents, restricted cash, and short-term investments totaled $4.6 million, insufficient to fund operations for the next twelve months.

  • Management has identified a material weakness in internal controls, which remains unremediated as of September 30, 2024.

Financial highlights

  • Product revenue for the nine months ended September 30, 2024 was $3.0 million, down from $8.1 million year-over-year.

  • Gross margin declined to 25% from 65% year-over-year, mainly due to lower collaboration revenue and increased inventory reserves.

  • Operating expenses decreased to $26.1 million from $37.6 million year-over-year, driven by headcount reductions and cost controls.

  • Net loss per share for the nine months was $(17.20), compared to $(18.58) in the prior year.

  • Cash used in operating activities was $15.5 million for the nine months ended September 30, 2024.

Outlook and guidance

  • Management expects current cash and investments will not be sufficient to fund operations for at least twelve months from the financial statement issuance date.

  • The company plans to seek additional financing through equity, debt, or strategic transactions but faces uncertainty regarding availability and terms.

  • Ongoing cost reduction efforts are expected to continue, with a focus on sales and marketing of developed products.

Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

The essential earnings season companion

The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Telesis Bio Inc. is a synthetic biology company that provides automated solutions for DNA and RNA synthesis. Its core product, the BioXp system, is the world’s first fully automated gene synthesis platform, enabling researchers to rapidly design, build, and clone high-quality synthetic DNA and mRNA. Telesis Bio's technologies are widely used in various applications, including vaccine development, gene and cell therapy, precision medicine, and biologics drug discovery. Telesis Bio is headquartered in San Diego, California, and its shares are listed on the Nasdaq.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage